Interviewer-Administered followed by Self-Administration for Alcohol Abuse

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Baylor Scott and White Community Care, Dallas, TX
Alcohol Abuse+5 More
Screening - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The goal of this study is to validate the TAPS-ESP as a screen and assessment that can be used in primary care for the screening and treatment of substance use.

Eligible Conditions

  • Alcohol Abuse
  • Drug abuse
  • Tobacco Use
  • Substance Use

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Alcohol Abuse

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: 1 year

1 year
Alcohol Use Disorders Identification Test (AUDIT) for concurrent and convergent validity of the TAPS
Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) for concurrent and convergent validity of the TAPS Tool
CAGE (Cut Down, Annoyed, Guilty, Eye-Opener) for concurrent and convergent validity of the TAPS
Drug Abuse Screening Test (DAST-10) for concurrent and convergent validity of the TAPS Tool
Fagerstrom Test for Nicotine Dependence (FTND) for concurrent and convergent validity of the TAPS
Tobacco, Alcohol, Prescription drug, and illicit Substance Use Tool-Electronic Spanish Platform (TAPS-ESP) primary criterion validation against the modified World Mental Health Composite International Diagnostic Interview (CIDI) in Spanish

Trial Safety

Safety Progress

1 of 3

Other trials for Alcohol Abuse

Trial Design

2 Treatment Groups

Interviewer-Administered followed by Self-Administration
1 of 2
Self-Administration followed by Interviewer-Administered
1 of 2
Active Control

1000 Total Participants · 2 Treatment Groups

Primary Treatment: Interviewer-Administered followed by Self-Administration · No Placebo Group · N/A

Interviewer-Administered followed by Self-Administration
Other
ActiveComparator Group · 1 Intervention: Screening · Intervention Types: Other
Self-Administration followed by Interviewer-Administered
Other
ActiveComparator Group · 1 Intervention: Screening · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year
Closest Location: Baylor Scott and White Community Care · Dallas, TX
Photo of Dallas 1Photo of Dallas 2Photo of Dallas 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Alcohol Abuse
0 CompletedClinical Trials

Who is running the clinical trial?

COG AnalyticsOTHER
2 Previous Clinical Trials
130 Total Patients Enrolled
Baylor Research InstituteLead Sponsor
187 Previous Clinical Trials
185,186 Total Patients Enrolled
Katherine Sanchez, PhDPrincipal InvestigatorBaylor Scott and White Research Institute
2 Previous Clinical Trials
500 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.